CORY NAFZIGER: Open Payments
NPI 1912364050 · GREENSBORO, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$696 in 37 payments from 14 companies in 2025. Trend: 2023 $763 · 2024 $1,053 · 2025 $696
Food & beverage: $696
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 12 | $182 |
| Abbott Laboratories | 7 | $164 |
| Lilly USA, LLC | 4 | $66 |
| PFIZER INC. | 3 | $61 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $33 |
| ViiV Healthcare Company | 1 | $31 |
| Otsuka America Pharmaceutical, Inc. | 1 | $29 |
| Esperion Therapeutics, Inc. | 1 | $23 |
| Exact Sciences Corporation | 1 | $21 |
| Hologic Sales and Service, LLC | 1 | $20 |
Products named: FREESTYLE LIBRE 3, Wegovy, Ozempic, MOUNJARO, PREVNAR 20, JARDIANCE, APRETUDE, REXULTI.
Industry payments across NC — which companies pay providers there.
